Author(s)

Balp M¹, Abuzakouk M², Berard F³, Canonica GW⁴, Gimenez-Arnau A⁵, Hollis K⁶, Khalil S¹, Knulst A⁷, Lacour J⁸, Lynde C⁹, Marsland A¹⁰, Maurer M¹¹, McBride D¹², Nakonechna A¹³, Ortiz de Frutoz FJ¹⁴, Oude Elberink J¹⁵, Proctor C⁶, Sussman G¹⁶, Weller K¹¹, Grattan C^17
1Novartis Pharma AG, Basel, Switzerland, ²Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates, ³Claude Bernard University Lyon, Lyon, France, ⁴University of Genoa, Genoa, Italy, ⁵Hospital del Mar. Parc de Salut Mar, Barcelona, Spain, ⁶RTI Health Solutions, Research Triangle Park, NC, USA, ⁷University Medical Center Utrecht, Utrecht, The Netherlands, ⁸Université Nice Sophia Antipolis, Nice Cedex 2, France, ⁹Lynderm Research Inc., Toronto, ON, Canada, ¹⁰Salford Royal Hospital and University of Manchester, Salford, UK, ¹¹Charite - Universitätsmedizin Berlin, Berlin, Germany, ¹²RTI Health Solutions, Manchester, UK, ¹³Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK, ¹⁴Hospital 12 Octubre, Madrid, Spain, ¹⁵University of Groningen, Groningen, The Netherlands, ¹⁶University of Toronto, Toronto, ON, Canada, ¹⁷Guy's Hospital, London, UK

Presentation Documents

• PSS22--strong-u-balp-m-u-sup-1-sup-strong-abuzakouk-m-sup-2-sup-berard-f-sup-3-sup-canonica-gw-sup-4-sup-gimenez-arnau-a-sup-5-sup-hollis-k-sup-6-sup-khalil-s-sup-1-sup-knulst-a-sup-7-sup-lacour-j-sup-8-sup-lynde-c-sup-9-sup-marsland-a-sup- ...